May. 15, 2025 |
|
June. 03, 2025 |
|
jRCTs061250017 |
High concentrated sodium citrate versus ACD-A for leukapheresis without heparin using centrifugal separation : Open-label, randomized, controlled trial |
|
ACD-HC trial |
Fujii Keiko |
||
Okayama University Hospital |
||
2-5-1, Shikata-cho, Kita-ku, Okayama |
||
+81-86-235-7768 |
||
keikofujii@s.okayama-u.ac.jp |
||
Fujii Keiko |
||
Okayama University Hospital |
||
2-5-1, Shikata-chi, Kita-ku, Okayama |
||
+81-86-235-7768 |
||
keikofujii@s.okayama-u.ac.jp |
Recruiting |
May. 15, 2025 |
||
May. 23, 2025 | ||
40 | ||
Interventional |
||
randomized controlled trial |
||
open(masking not used) |
||
no treatment control/standard of care control |
||
single assignment |
||
treatment purpose |
||
PBSC donor |
||
Peripheral blood stem cell donors registered with the Japan Marrow Donor Program |
||
16age old over | ||
No limit | ||
Both |
||
PBSC donor |
||
Peripheral blood stem cell collection using 5.3% sodium citrate solution (ACD-HC) |
||
procedure time due to apheresis |
||
total amount of AC |
Okayama University Certified Review Bord | |
2-5-1, Shikata-cho, Kita-ku, Okayama, Okayama | |
+81-86-235-6503 |
|
ouh-crrb@adm.okayama-u.ac.jp | |
Approval | |
May. 02, 2025 |
none |